Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Matthew I. Quesenberry"'
Autor:
Arun Muthiah, Vanya Aggarwal, Chandrasekar Muthiah, Chapman Wei, Thomas Ollila, Matthew I. Quesenberry, Don S. Dizon
Publikováno v:
JCO Oncology Practice. 18:e600-e609
PURPOSE: Hematology and oncology (HO) lags behind all medicine subspecialties in fellows under-represented in medicine (URM) despite a growing minority patient population. Websites have been effectively used in URM recruitment. We evaluated all US HO
Autor:
Andrew Schumacher, William M Sikov, Matthew I Quesenberry, Howard Safran, Humera Khurshid, Kristen M Mitchell, Adam J Olszewski
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172957 (2017)
BACKGROUND:Informed consent forms (ICFs) for oncology clinical trials have grown increasingly longer and more complex. We evaluated objective understanding of critical components of informed consent among patients enrolling in contemporary trials of
Externí odkaz:
https://doaj.org/article/01cc5eedb1db40f8b3b5e27bf9de8f7d
Autor:
Adam E.M. Eltorai, Jack H. Ruddell, Matthew I. Quesenberry, Shaan A Ahmed, Oliver Y. Tang, Fred J. Schiffman
Publikováno v:
Journal of Oncology Practice. 15:e439-e446
PURPOSE: Prospective hematology-oncology fellowship applicants use program Web sites as a critical source of information. The purpose of this study was to evaluate the current content and comprehensiveness of hematology-oncology fellowship Web sites
Autor:
Matthew I. Quesenberry, Arun Muthiah, Chapman Wei, Don S. Dizon, Vanya Aggarwal, Chandrasekar Muthiah
Publikováno v:
Journal of Clinical Oncology. 39:11004-11004
11004 Background: Fellowship in hematology and oncology (HO) is widely sought after but lags behind all other internal medicine subspecialties in attracting applicants underrepresented in medicine (URM). An approach to appealing to URMs involves pree
Autor:
Adam Fitch, Loren D. Fast, Kelvin Li, Philippa G. Sprinz, Laura R. Goldberg, Seah H. Lim, Matthew I. Quesenberry, Barbara Methé, Alison Morris
Publikováno v:
American Journal of Hematology. 93:E91-E93
Autor:
Matthew I. Quesenberry, Rabin Niroula, John L. Reagan, Adam Zayac, Pamela C Egan, Peter J. Quesenberry, Thomas A Ollila, James N. Butera, Loren D. Fast, Peter Barth, Adam J. Olszewski
Publikováno v:
Blood. 134:4460-4460
Background: Allogeneic stem cell transplant (allo-SCT) is a cornerstone in the treatment of Acute Myeloid Leukemia (AML) exerting much of its therapeutic efficacy through the graft-versus-leukemia effect. The administration of immunoregulatory cells
Autor:
Matthew I. Quesenberry, Neel Belani, Rabin Niroula, Adriel Barrios-Anderson, William Rafelson
Publikováno v:
Blood. 134:4909-4909
Background: Thrombotic Thrombocytopenic Purpura (TTP) is a form of microangiopathic hemolytic anemia that is classically characterized by the clinical pentad of fever, hemolytic anemia, thrombocytopenia, renal dysfunction, and neurologic dysfunction.
Autor:
Adam J. Olszewski, Matthew I. Quesenberry, Peter J. Quesenberry, John L. Reagan, James N. Butera, Thomas A Ollila
Publikováno v:
Clinical lymphoma, myelomaleukemia. 18(3)
Induction chemotherapy for acute myeloid leukemia (AML) is based on the "7+3" cytarabine/anthracycline regimen. A nonhypocellular day 14 (D14) bone marrow sample with a blast count5% to 10% is suggestive of residual leukemia, for which a second cours
Autor:
Heather W. Pinkett, Christopher L. Graham, Matthew I. Quesenberry, Katherine W. Klinger, Raman Sood, John D. Carpten, Timothy D. Connors, Jeffrey M. Trent, Andreas D. Baxevanis, Christiane M. Robbins, Kui Su, Izabela Makalowska, Tom I. Bonner, Sharon D. Morgenbesser, Dietrich A. Stephan
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1491:285-288
Ral GDP dissociation stimulator (RalGDS) and its family members RGL, RLF and RGL2 are involved in Ras and Ral signaling pathways as downstream effector proteins. Here we report the precise localization and cloning of two forms of human RGL gene diffe